Impact Biomedical Inc.
IBO- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001834105
In the last 90 days, Impact Biomedical Inc. insiders filed 0 open-market purchases and 1 sale; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.76M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Impact Biomedical Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 11 | 17 | +6 |
| Shares | 89.1K | 385.8K | +296.8K (+333.2%) |
| Value | $76.1K | $335.4K | +$259.2K (+340.5%) |
New holders (7)
Institutions that held Impact Biomedical Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 126,446 | $110.0K | 0.00% |
| HRT Financial LP | 68,158 | $59.0K | 0.00% |
| Citadel Advisors LLC | 60,315 | $52.5K | 0.00% |
| BlackRock, Inc. | 30,675 | $26.7K | 0.00% |
| Morgan Stanley | 7,800 | $6.79K | 0.00% |
| Signature Resources Capital Management, LLC | 4 | $3 | 0.00% |
| CWM, LLC | 1 | $0 | 0.00% |
Sold out (1)
Institutions that held Impact Biomedical Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| FNY Investment Advisers, LLC | 12,600 | $18.0K |